Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DarioHealth Corp. - Common Stock (NQ:DRIO)

0.6499 -0.0101 (-1.53%)
Streaming Delayed Price Updated: 10:33 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DarioHealth Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces 1st Contract with Government Benefits Entity
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Promising Clinical Research for Its Biofeedback Posture Device
Via Investor Brand Network
US Stocks Open Higher Ahead Of Fed Decision, Dow Jumps 175 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 175 points on Wednesday. The Federal Reserve will announce its policy decision at 2:00 p.m. ET. The country’s central bank is... 
Via Benzinga
Looking Into DarioHealth's Return On Capital Employed
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter. 
Via Benzinga
DarioHealth: Q2 Earnings Insights
  DarioHealth (NASDAQ:DRIO) reported its Q2 earnings results on Monday, August 15, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: DarioHealth Q1 Earnings
DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
DarioHealth Corp. (NASDAQ: DRIO) recently announced 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2022 Financial Report, Corporate Update
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research at Conference Showing Support for Rural Areas
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Solution to Drive Digital, Seamless Experience for National Health Plan
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q2 Earnings Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Research Regarding Digital Solution on Depression, Anxiety at APA Convention
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Multi-Chronic Contract with National Employer for Full-Solution Suite
Via Investor Brand Network
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Contract with National Employer
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions
Via Investor Brand Network
DarioHealth Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million. 
Via Benzinga
Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET)
Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with OrbiMed to Close on $50 Million Credit Facility
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presenting Key Findings from Three New Studies at ADA Scientific Sessions
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Commercial Contracts as Market Develops Appreciation for Integrated Digital Solutions
Via Investor Brand Network
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
Upgrades 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Record Quarterly Revenues in Q1 2022
Via Investor Brand Network
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... 
Via Benzinga
Earnings Outlook For DarioHealth
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q1 2022 Results, Conference Call
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research Supporting ‘Digital Solutions That Prioritize a Whole Health Experience’
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.